Clinical Leader
Ivan Borbath
JOB TITLE
Pr. Medical Director
Hepato-gastro-enterology dept, expertise in digestive oncology
ROLE
Clinical Leader of Use Case #4: Prediction of cardiac complications due to HCC treatments
INSTITUTION
Cliniques universitaires Saint-Luc
Scientific Leaders
Stefan Hoehme
JOB TITLE
Prof. Dr. Project Leader
ROLE
Scientific Leader of Use Case #4: Prediction of cardiac complications due to HCC treatments
INSTITUTION
Universitat Leipzig
Nicolas Lanthier
JOB TITLE
Prof.Dr of Gastroenterology and Hepatology Clinical researcher Expert in MASLD/MASH and cirrhosis
ROLE
Clinical Leader of Use Case #4: Prediction of cardiac complications due to HCC treatments
INSTITUTION
Cliniques universitaires Saint-Luc (CUSL)
Case overview
Finally Use Case 4 focuses on predicting cardiac complications due to hepatocellular carcinoma (HCC) treatments, for well-established therapies at different stages (e.g. partial hepatectomy or transplantation in early stages; Loco-regional therapy (LRT, such as chemoembolization/TACE or radioembolization/SIRT) as a first-line therapy in intermediate stage; immunotherapies or Tyrosine kinase inhibitors (TKIs) as systematic therapy for advanced stage).
